A Study of LSTA1 When Added to Standard of Care Versus Standard of Care Alone in Patients With Advanced Solid Tumors
Trial details
- Registry ID
- NCT05712356
- Phase
- Phase 2
Drug identity checked against registry records
Also recorded as CEND-1; LSTA1
| Trial | Sponsor | Phase | Status | Primary completion |
|---|---|---|---|---|
| A Study of LSTA1 When Added to Standard of Care Versus Standard of Care Alone in Patients With Advanced Solid TumorsNCT05712356 | LSTA | Phase 2 | Completed | 2026-04-05Actual |
| No regulatory events match this view.This does not mean no FDA events have occurred. |